🔥 Trending FDA Approves New Over-the-Counter Tylenol Combination Pill for Pain Relief

The U.S. Food and Drug Administration (FDA) has recently approved a new over-the-counter (OTC) combination pill that merges acetaminophen (the active ingredient in Tylenol) with naproxen sodium (a nonsteroidal anti-inflammatory drug, or NSAID) ¹²⁴. This new product, marketed as TYLENOL® with Naproxen, is designed to provide effective pain relief ³⁸.

Key Features and Significance of the New Pill

This approval marks a significant development in the realm of OTC pain management for several reasons:

First-of-its-Kind Combination

While other combination products containing acetaminophen and NSAIDs exist, this is the first OTC product to combine naproxen sodium with acetaminophen ⁵. The FDA specifically noted that this fixed-dose combination offers a unique approach to pain relief ⁵.

Opioid-Free Pain Relief

TYLENOL® with Naproxen is highlighted as an opioid-free option for pain relief ³⁷. This is particularly relevant given ongoing efforts to provide effective alternatives to opioid medications.

Fast-Acting and Long-Lasting

According to the manufacturer, the pill begins working in under 30 minutes and provides 12 hours of pain relief with a single dose ³. This extended duration of action could be beneficial for individuals seeking sustained relief.

Active Ingredients

The approved combination tablet contains 325 mg of acetaminophen and 110 mg of naproxen sodium ⁷. It is classified as both an analgesic (pain reliever) and an NSAID ⁸.

Context of Approval

The FDA's approval of this OTC medication aligns with federal efforts to make more verified safe pharmaceutical drugs available for over-the-counter purchase, as part of initiatives like "The Great Healthcare Plan" ².

Manufacturer

The new combination pill is from Kenvue, the company behind the Tylenol brand ⁴⁶⁸.

The approval date for TYLENOL® with Naproxen was July 24, 2026 ⁴⁶⁸. This new option is expected to be available over-the-counter for temporary pain relief ⁸.